These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2373132)

  • 1. The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.
    Poirier JM; Jaillon P; Lecocq B; Lecocq V; Ferry A; Cheymol G
    Eur J Clin Pharmacol; 1990; 38(6):579-82. PubMed ID: 2373132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetic and pharmacodynamic properties of oral and intravenous (+)-sotalol in healthy volunteers.
    Uematsu T; Kanamaru M; Nakashima M
    J Pharm Pharmacol; 1994 Jul; 46(7):600-5. PubMed ID: 7996391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of (+/-)-sotalol in healthy male volunteers.
    Kimura M; Umemura K; Ikeda Y; Kosuge K; Mizuno A; Nakanomyo H; Ohashi K; Nakashima M
    Br J Clin Pharmacol; 1996 Nov; 42(5):583-8. PubMed ID: 8951189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sotalol enantiomers in humans.
    Carr RA; Foster RT; Lewanczuk RZ; Hamilton PG
    J Clin Pharmacol; 1992 Dec; 32(12):1105-9. PubMed ID: 1487548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of sotalol.
    Hanyok JJ
    Am J Cardiol; 1993 Aug; 72(4):19A-26A. PubMed ID: 8346722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific evaluation of sotalol pharmacokinetics in a rat model: evidence suggesting an enantiomeric interaction.
    Carr RA; Pasutto FM; Foster RT
    Biopharm Drug Dispos; 1994 Mar; 15(2):109-20. PubMed ID: 8011963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective disposition of (+/-)-sotalol at steady-state conditions.
    Fiset C; Philippon F; Gilbert M; Turgeon J
    Br J Clin Pharmacol; 1993 Jul; 36(1):75-7. PubMed ID: 8373714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
    Funck-Brentano C
    Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects.
    Salazar DE; Much DR; Nichola PS; Seibold JR; Shindler D; Slugg PH
    J Clin Pharmacol; 1997 Sep; 37(9):799-809. PubMed ID: 9549633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sotalol during pregnancy.
    O'Hare MF; Leahey W; Murnaghan GA; McDevitt DG
    Eur J Clin Pharmacol; 1983; 24(4):521-4. PubMed ID: 6861867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.
    Deneer VH; Lie-A-Huen L; Kingma JH; Proost JH; Kelder JC; Brouwers JR
    Br J Clin Pharmacol; 1998 May; 45(5):485-90. PubMed ID: 9643622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- and multiple-dose pharmacokinetics of sotalol hydrochloride in healthy cats.
    Salmon SJ; Coleman AE; Lynn CR; Sanders JE; Messenger KM
    J Vet Cardiol; 2024 Feb; 51():86-96. PubMed ID: 38118234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of propranolol and sotalol pharmacokinetics in obese subjects.
    Poirier JM; Le Jeunne C; Cheymol G; Cohen A; Barré J; Hugues FC
    J Pharm Pharmacol; 1990 May; 42(5):344-8. PubMed ID: 1976782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple HPLC-fluorescence method for the measurement of R,S-sotalol in the plasma of patients with life-threatening cardiac arrhythmias.
    Santos SR; Papini O; Omosako CE; Pereira MD; Quintavalle TB; Riccio MF; Kurata A; Pereira VA; Di-Pietro G; Della-Paschoa OE; Danhof M; Da-Luz PL
    Braz J Med Biol Res; 2000 Feb; 33(2):199-204. PubMed ID: 10657059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate.
    Geisslinger G; Menzel S; Wissel K; Brune K
    Br J Clin Pharmacol; 1995 Jul; 40(1):73-5. PubMed ID: 8527271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pharmacokinetics of sotalol.
    Anttila M; Arstila M; Pfeffer M; Tikkanen R; Vallinkoski V; Sundquist H
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):118-28. PubMed ID: 988964
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.
    Neugebauer G; Akpan W; Kaufmann B; Reiff K
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S108-11. PubMed ID: 1974498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Testing of bioequivalence of a new sotalol hydrochloride preparation in comparison to a standard formulation].
    Herrmann R; Kleinbloesem CH
    Arzneimittelforschung; 1995 Aug; 45(8):849-52. PubMed ID: 7575745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective high-performance liquid chromatographic assay for the determination of sotalol enantiomers in biological fluids.
    Fiset C; Philippon F; Gilbert M; Turgeon J
    J Chromatogr; 1993 Feb; 612(2):231-7. PubMed ID: 8468381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.